Funded Tech Companies
Ensoma
Wondering who provided funding to Ensoma? Symbiosis, Mirae Asset Venture Investment and Delos Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Ensoma
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
75 Kneeland St. 14th Floor
Boston, MA 02111
USA
Boston, MA 02111
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
At Ensoma, we believe every person, no matter where they are in the world, should have access to innovative technologies that are changing the way we treat disease. Harnessing the power of our Engenious vectors, we can deliver, for the first time, in vivo stem cell modification technologies without the need for prior conditioning or stem cell collection.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/22/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Paula Soteropoulos
Chief Executive Officer
Kush Parmar
Chief Scientific Officer
Robert Peters
Chief Technical Officer
Daniel Leblanc
VP - Bus. Development
Naina Bhasin
VP - Regulatory Affairs
Patrick Au
Company Investors
- Symbiosis
- Mirae Asset Venture Investment
- Delos Capital
- Catalio Capital Management
- F-Prime Capital
- Solasta Ventures
- 5AM Ventures
- Hanwha Impact Partners
- RTW Investments
- Gilead Sciences
- Viking Global Investors
- Cormorant Asset Management
- Bill & Melinda Gates Foundation
- Qatar Investment Authority
- Kite Pharma
- Bioluminescence Ventures
- Takeda Ventures
- Alexandria Venture Investments
- Arix Bioscience (Mark Chin)
- Fred Hutchinson Cancer Center
- Mirae Asset Capital
- RIT Capital Partners
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs